Remove Definition Remove Hospital Remove Radiation Oncology
article thumbnail

ASTRO and ESTRO Issue Clinical Guideline on Local Therapy for Oligometastatic Lung Cancer

Imaging Technology

The guideline is published in Practical Radiation Oncology. A growing body of research, however, points to an additional role for definitive local therapy to all disease sites, aiming at durable tumor control and improved survival outcomes.

article thumbnail

Koneksa Announces Study with New York Proton Center to Collect Patient-Generated Health Data During Proton Radiotherapy in Lung Cancer

Imaging Technology

a professor in Radiation Oncology at the Montefiore Einstein Comprehensive Cancer Center , aims to demonstrate the feasibility of PGHD collection during proton beam radiotherapy for lung cancer. These adverse events often lead to hospitalizations and treatment interruptions that can reduce treatment efficacy.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

GE HealthCare Closes MIM Software Acquisition

Imaging Technology

These new capabilities align with our precision care strategy to personalize care, enhance hospital efficiency and clinician effectiveness, and appeal to new and existing GE HealthCare and MIM Software users who see this as an opportunity to better serve patients and help improve outcomes." Oncotarget. 2017 Jun 8;8(37):62742-62758.

article thumbnail

PET/CT radiomics predicts outcomes in women with cervical cancer

AuntMinnie

Finally, in a cohort of 23 patients from another hospital, the nomogram predicted 3-year progression-free survival (PFS) in patients with LACC with an area under the operating curve (AUC) of 76% and 5-year PFS with an AUC of 68%, according to the findings. “We

Clinic 118
article thumbnail

The rise of theranostics: Part 3 -- What is a theranostics center?

AuntMinnie

Eliot Siegel, MD; Stanislav Spiridonov, MD; Nathan Gee, MD; and Anthony Chang, PhD, are among a niche gathering of early adopters, entrepreneurial physicians, medical physicists, and investors with a sweet spot for nuclear medicine, diagnostic radiology, and radiation oncology. led by Harshad Kulkarni, MD, as principal investigator.